Pooja Ghatalia Joins the Faculty at Fox Chase Cancer Center

PHILADELPHIA (July 2, 2018) – Fox Chase Cancer Center is pleased to announce the hiring of Pooja Ghatalia, MD, as an assistant professor in the Department of Hematology/Oncology. Ghatalia will join the faculty after graduating from a three-year hematology/oncology fellowship, which she began at Fox Chase in 2015.

Ghatalia is an award-winning researcher, having received the Kidney Cancer Association Young Investigator Award in 2017. She used the grant to fund her study entitled, “Characterization of Tumor Infiltrating Immune Cells and Development of Immune Gene Signature in Localized Clear Cell Renal Cell Carcinoma.” The study was a continuation of the work she began during her internal medicine residency, and aimed to identify an immune gene signature to predict which patients with localized renal cancer might experience a recurrence.  She has authored multiple publications in bladder and kidney cancer.

“I’m incredibly grateful to be able to continue my work as a kidney cancer clinician-researcher at Fox Chase Cancer Center,” said Ghatalia. “I look forward to providing the best possible care to patients and their families, and continuing to learn from my mentors here.”

She will start in her new position on July 1.

“We’re thrilled to welcome Dr. Ghatalia to our faculty” said Elizabeth Plimack, MD, chief of genitourinary medical oncology at Fox Chase. “She has already shown a great deal of promise as a physician and scientist. We look forward to building on that foundation and having her as part of our multidisciplinary patient care team.”

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427